Core Viewpoint - Autonomix Medical (NASDAQ:AMIX) experienced significant stock volatility, with a notable rally followed by a decline in share price due to market reactions and company announcements [1][6]. Group 1: Stock Performance - AMIX stock rallied 130% during normal trading hours yesterday, with approximately 152 million shares traded, significantly above its daily average of about 3 million shares [5]. - Following the rally, AMIX stock is down 16.7% as of Tuesday morning, indicating a correction after the previous day's gains [6]. Group 2: Company Developments - Autonomix Medical announced a definitive agreement with RF Innovations to license the intellectual property of its Apex 6 Radiofrequency Generator, expected to be completed by the end of the month [2]. - The company provided updates on its pancreatic cancer pain management device, reporting positive results from a clinical trial that utilizes radiofrequency (RF) ablation to alleviate pain in pancreatic cancer patients [4].
Why Is Autonomix Medical (AMIX) Stock Down 17% Today?